Embattled GlaxoSmithKline boss Emma Walmsley expected to reinforce her defences against Elliott when pharma giant posts improving revenues By Alex Lawson, Financial Mail On Sunday Published: 16:50 EDT, 24 July 2021 | Updated: 17:22 EDT, 24 July 2021 Embattled GlaxoSmithKline chief Emma Walmsley is expected to reinforce her defences against corporate raider Elliott this week … Read more
GSK to fast track breakthrough Covid drug after trials found it cut deaths and hospitalisations by 85% By Matt Oliver For The Daily Mail Published: 22:03 GMT, 11 March 2021 | Updated: 22:03 GMT, 11 March 2021 A breakthrough Covid-19 drug is being put forward for emergency use by Glaxosmithkline after trials found it cut … Read more
GSK strikes £132m deal with CureVac to develop vaccines for Covid variants as it reveals lacklustre annual results A total of £132m will be invested by GlaxoSmithKline into CureVac’s research Demand for GSK-made pain relief and digestive health products grew strongly GSK’s largest division, Pharmaceuticals, saw its sales drop 3% to £17.1bn By Harry Wise … Read more
GSK Covid vaccine is delayed: British pharmaceutical giant GlaxoSmithKline that is due to supply 60m doses of jab to Britain announces hold-up after ‘insufficient trial responses’ in elderly The UK in July secured 60million doses of the treatment among other jabs Any Sanofi/GSK jab will now not likely be ready before the end of 2021 … Read more
British drug giants Astrazeneca and Glaxosmithkline still in the race for a Covid jab By Matt Oliver For The Daily Mail Published: 21:53 GMT, 9 November 2020 | Updated: 22:20 GMT, 9 November 2020 Britain’s two biggest drugs companies are also developing Covid-19 vaccines. Potential jabs are being tested by FTSE 100 giants Astrazeneca and … Read more
GSK gears up for trials as it pushes ahead with three possible Covid-19 vaccines and two antibody treatments The British drugs group is also shipping record amounts of flu jabs GSK warned that the pandemic continued to disrupt other parts of its business But the firm said it would still pay out a dividend, expected … Read more
Conflict of interest row as it emerges Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker contracted to make UK’s coronavirus jabs Sir Patrick was president of multinationals drugs giant GSK from 2012 to 2018 Chief Scientific Adviser holds a deferred bonus of 43,111 shares worth £600,000 He has already cashed in … Read more
University of Oxford Oxford University academics began developing the ChAdOx1 nCoV-19 vaccine in January. It is now named AZD1222, after the researchers signed a manufacturing partnership with pharmaceutical giant AstraZeneca. Human trials started on April 23 and they are now in the final phase, with trials being carried out in the UK, Brazil and South … Read more